OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$5.95
· % 处于52周区间
· 高于低点
· 至高点
$2.6652周低点
$6.5052周高点
市值 (MRQ)
$358M
P/E (TTM)
-7.2
EPS (TTM)
$-0.83
收入 (TTM)
$32M
OBIO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$5.95
市值 (MRQ)
$358M
P/E (TTM)
-7.2
EPS (TTM)
$-0.83
收入 (TTM)
$32M
ROE (TTM)
-601.8%
52周区间
$3–$7
OBIO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$33M2022-12-31 → 2025-12-31
EPS$-1.112021-12-31 → 2025-12-31
自由现金流$-49M2023-12-31 → 2025-12-31
净利率-184.6%2023-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | OBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -7.25年均值 ≈-104.2 | ≈-104.2 | · | · | |
| P/S (TTM) | 11.25年均值 ≈49.0 | ≈49.0 | 5.5 | 估值过高 | |
| 市净率 (MRQ) | 18.55年均值 ≈-0.8 | ≈-0.8 | 4.6 | 估值过高 | |
| 股价/自由现金流 (TTM) | -6.15年均值 ≈-5.0 | ≈-5.0 | · | · | |
| 市现率 (TTM) | -6.15年均值 ≈-41.6 | ≈-41.6 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 6.35年均值 ≈3.7 | ≈3.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | OBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -181.4%5年均值 ≈-1486.1% | ≈-1486.1% | -58.4% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -180.3%5年均值 ≈-1478.4% | ≈-1478.4% | -58.4% | 弱 | |
| 净利润率 (TTM) | -184.6%5年均值 ≈-1416.8% | ≈-1416.8% | -57.3% | 弱 | |
| ROA (TTM) | -74.5%5年均值 ≈-36.1% | ≈-36.1% | -32.6% | 弱 | |
| ROE (TTM) | -601.8%5年均值 ≈-83.3% | ≈-83.3% | -106.9% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | OBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 8.35年均值 ≈5.9 | ≈5.9 | 4.9 | 流动性强 | |
| 速动比率 (MRQ) | 8.25年均值 ≈5.8 | ≈5.8 | 3.7 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | OBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 1169.2%5年均值 ≈381.0% | ≈381.0% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 111.6% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | OBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.45年均值 ≈0.1 | ≈0.1 | 0.6 | 弱 | |
| Inventory Turnover (库存周转率) | 0.85年均值 ≈1.0 | ≈1.0 | 1.5 | 弱 | |
| Receivables Turnover (应收账款周转率) | 358.15年均值 ≈138.0 | ≈138.0 | 6.6 | 顶尖 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$389.3K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
18.1%
下次报告
十一月 09, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 18, 2026 | $-0.38 | $-0.40 | 5.0% |
| 2026年3月31日 | 五月 18, 2026 | $-0.33 | $-0.44 | 24.9% |
| 2025年12月31日 | $-0.13 | $-0.39 | 66.3% | |
| 2025年9月30日 | $-0.40 | $-0.44 | 9.8% | |
| 2025年6月30日 | $-0.50 | $-0.51 | 2.7% | |
| 2025年3月31日 | $-0.49 | $-0.49 | 0.12% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $33M | $3M | $3M | $4M | |
| Cost of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | |
| R&D Expense | $58M | $43M | $34M | $22M | |
| SG&A Expense | $27M | $24M | $20M | $14M | |
| Operating Expenses | $85M | $67M | $54M | $36M | |
| Operating Income | $-52M | $-64M | $-52M | $-33M | |
| Interest Income | · | · | · | $345.1K | |
| Other Non-op | · | $-11.0K | · | · | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-53M | $-61M | $-49M | $-34M | |
| EPS (Basic) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| Shares (Basic) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| Shares (Diluted) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| EBITDA | $-51M | $-64M | $-51M | $-3M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $22M | $31M | $20M | |
| Short-term Investments | $72M | $45M | $57M | $64M | |
| Receivables | $95.0K | $92.0K | $99.0K | $96.0K | |
| Inventory | $310.0K | $173.0K | $146.0K | $276.0K | |
| Prepaid Expense | $994.0K | $2M | $1M | $533.0K | |
| Current Assets | $108M | $69M | $89M | $85M | |
| PP&E (Net) | $2M | $1M | $1M | $1M | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $778.0K | |
| Total Assets | $115M | $76M | $95M | $96M | |
| Accounts Payable | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $10M | $6M | $5M | $5M | |
| Current Liabilities | $17M | $16M | $11M | $19M | |
| Capital Leases | $936.0K | $2M | $1M | $2M | |
| Deferred Tax | $393.0K | $561.0K | $508.0K | $637.0K | |
| Other Non-current Liabilities | $308.0K | $40.0K | · | $196.0K | |
| Total Liabilities | $51M | $43M | $27M | $43M | |
| Long-term Debt | $15M | $15M | · | · | |
| Common Stock | $6.0K | $4.0K | $4.0K | $2.0K | |
| Paid-in Capital | $416M | $343M | $317M | $252M | |
| Retained Earnings | $-363M | $-310M | $-249M | $-200M | |
| AOCI | $60.0K | $52.0K | $-10.0K | $-8.0K | |
| Stockholders' Equity | $54M | $33M | $68M | $53M | |
| Liabilities + Equity | $115M | $76M | $95M | $96M | |
| Shares Outstanding | 57,032,963 | 38,194,442 | 35,777,412 | 20,187,850 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $327.0K | $308.0K | $287.0K | $222.0K | |
| Stock-based Comp | $12M | $11M | $8M | $3M | |
| Other Non-cash | $-9M | $-457.0K | $-5M | · | |
| Operating Cash Flow | $-49M | $-51M | $-46M | $-29M | |
| CapEx | $489.0K | $289.0K | $78.0K | $591.0K | |
| Investing Cash Flow | $-27M | $13M | $11M | $-64M | |
| Net Debt Issued | · | · | $-11M | · | |
| Financing Cash Flow | $88M | $29M | $46M | $103M | |
| Net Change in Cash | $12M | $-8M | $11M | $10M | |
| Free Cash Flow | $-49M | $-51M | $-46M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -154.7% | -2437.5% | -1866.2% | · | |
| Net Margin | -157.4% | -2313.3% | -1779.7% | · | |
| EBITDA Margin | -153.8% | -2425.8% | -1855.8% | · | |
| ROA | -55.2% | -71.2% | -51.5% | -2.4% | |
| ROE | -195.7% | -154.2% | -66.5% | -10.0% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 6.4 | 4.3 | 8.0 | 0.2 | |
| Quick Ratio | 6.4 | 4.1 | 7.8 | 0.1 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.8 | 1.3 | 0.9 | · | |
| Receivables Turnover | 358.1 | 27.6 | 28.3 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.94 | $0.86 | $1.90 | $-1.56 | |
| Revenue / Share | $0.70 | $0.07 | $0.08 | · | |
| Cash Flow / Share | $-1.03 | $-1.37 | $-1.39 | $-0.10 | |
| Cash / Share | $0.61 | $0.58 | $0.85 | $0.04 | |
| EPS (TTM) | $-1.11 | $-1.66 | $-1.48 | $-2.24 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1169.2% | -4.4% | -21.9% | · | |
| Revenue CAGR 3Y | 111.6% | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $33M | $3M | $3M | $4M | |
| Net Income TTM | $-53M | $-61M | $-49M | $-34M | |
| Market Cap | $237M | $153M | $327M | $44M | |
| P/E | -3.7 | -2.4 | -6.2 | -4.5 | |
| P/S | 7.1 | 57.9 | 118.4 | 12.6 | |
| P/B | 4.4 | 4.6 | 4.8 | -6.4 | |
| P / Tangible Book | 4.4 | 4.6 | 4.8 | 0.8 | |
| P / Cash Flow | -4.8 | -3.0 | -7.1 | -28.1 | |
| P / FCF | -4.8 | -3.0 | -7.1 | · | |
| Earnings Yield | -26.8% | -41.5% | -16.2% | -22.4% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $110.0K | $31M | $861.0K | $836.0K | $868.0K | $253.0K | $987.0K | $778.0K | $620.0K | $262.0K | $419.0K | $915.0K | $1M | $1M | $1M | |
| Cost of Revenue | $25.0K | $32.0K | $51.0K | $49.0K | $46.0K | $44.0K | $58.0K | $68.0K | $44.0K | $34.0K | $47.0K | $41.0K | $54.0K | $44.0K | $53.0K | $56.0K | |
| R&D Expense | $17M | $16M | $17M | $14M | $14M | $13M | $11M | $12M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | $6M | |
| SG&A Expense | $6M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $4M | $3M | $5M | |
| Operating Expenses | $22M | $22M | $24M | $21M | $20M | $20M | $17M | $17M | $18M | $15M | $13M | $15M | $14M | $13M | $11M | $11M | |
| Operating Income | $-22M | $-22M | $7M | $-20M | $-19M | $-19M | $-17M | $-16M | $-17M | $-14M | $-12M | $-15M | $-13M | $-12M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $351.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $-11.0K | · | · | · | · | · | · | |
| Net Income | $-24M | $-21M | $6M | $-21M | $-19M | $-19M | $-16M | $-15M | $-16M | $-13M | $-13M | $-13M | $-12M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| EPS (Diluted) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| Shares (Basic) | 63,812,098 | 62,721,869 | · | 52,186,503 | 38,392,716 | 38,235,409 | · | 37,621,495 | 35,800,273 | 35,777,877 | · | 35,243,598 | 34,613,466 | 27,643,549 | · | 20,187,773 | |
| Shares (Diluted) | 63,812,098 | 62,721,869 | · | 52,186,503 | 38,392,716 | 38,235,409 | · | 37,621,495 | 35,800,273 | 35,777,877 | · | 35,243,598 | 34,613,466 | 27,643,549 | · | 20,187,773 | |
| EBITDA | $-22M | $-22M | · | $-20M | $-19M | $-19M | · | $-16M | $-17M | $-14M | · | $-15M | $-13M | $-11M | · | $-813.4K |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $28M | $35M | $42M | $19M | $18M | $22M | $26M | $24M | $23M | $31M | $19M | $16M | $19M | $20M | $735.2K | |
| Short-term Investments | $89M | $66M | $72M | $54M | $15M | $32M | $45M | $41M | $41M | $52M | $57M | $89M | $101M | $108M | $64M | · | |
| Receivables | $51.0K | $84.0K | $95.0K | $52.0K | $83.0K | $89.0K | $92.0K | $115.0K | $80.0K | $67.0K | $99.0K | $86.0K | $171.0K | $76.0K | $96.0K | · | |
| Inventory | $250.0K | $277.0K | $310.0K | $365.0K | $185.0K | $135.0K | $173.0K | $234.0K | $70.0K | $115.0K | $146.0K | $137.0K | $178.0K | $232.0K | $276.0K | · | |
| Prepaid Expense | $977.0K | $1M | $994.0K | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $533.0K | $137.3K | |
| Current Assets | $111M | $96M | $108M | $98M | $36M | $52M | $69M | $69M | $66M | $76M | $89M | $110M | $120M | $130M | $85M | $872.6K | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $993.0K | $921.0K | $849.0K | $778.0K | · | |
| Total Assets | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Accounts Payable | $6M | $6M | $6M | $8M | $5M | $6M | $5M | $5M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $281.6K | |
| Accrued Liabilities | $7M | $7M | $10M | $7M | $7M | $5M | $6M | $7M | $4M | $4M | $5M | $4M | $4M | $3M | $5M | $1M | |
| Current Liabilities | $13M | $14M | $17M | $21M | $17M | $15M | $16M | $16M | $15M | $10M | $11M | $21M | $12M | $12M | $19M | $1M | |
| Capital Leases | $520.0K | $730.0K | $936.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | · | |
| Deferred Tax | · | · | $393.0K | · | · | · | $561.0K | · | · | · | $508.0K | · | · | · | $637.0K | · | |
| Other Non-current Liabilities | $397.0K | $367.0K | $308.0K | $248.0K | $189.0K | $99.0K | $40.0K | · | · | · | · | $266.0K | $213.0K | $249.0K | $196.0K | · | |
| Total Liabilities | $86M | $50M | $51M | $61M | $43M | $42M | $43M | $29M | $28M | $25M | $27M | $37M | $36M | $37M | $43M | $7M | |
| Long-term Debt | · | $15M | $15M | $15M | $15M | $15M | · | · | · | · | · | $10M | $10M | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $445 | |
| Paid-in Capital | $426M | $424M | $416M | $413M | $348M | $345M | $343M | $340M | $322M | $320M | $317M | $316M | $312M | $310M | $252M | · | |
| Retained Earnings | $-407M | $-383M | $-363M | $-369M | $-348M | $-329M | $-310M | $-294M | $-278M | $-262M | $-249M | $-236M | $-223M | $-211M | $-200M | $-6M | |
| AOCI | $-81.0K | $-40.0K | $60.0K | $45.0K | $16.0K | $37.0K | $52.0K | $98.0K | $-23.0K | $-8.0K | $-10.0K | $-77.0K | $-96.0K | $-35.0K | $-8.0K | · | |
| Stockholders' Equity | $19M | $41M | $54M | $44M | $295.0K | $17M | $33M | $46M | $44M | $57M | $68M | $80M | $89M | $100M | $53M | $-6M | |
| Liabilities + Equity | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Shares Outstanding | 60,105,049 | 58,630,715 | 57,032,963 | 56,464,731 | 38,643,553 | 38,312,512 | 38,194,442 | 37,942,905 | 35,824,571 | 35,784,997 | 35,777,412 | 35,743,972 | 35,743,007 | 31,741,147 | 20,187,850 | 4,450,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96.0K | $90.0K | $82.0K | $81.0K | $81.0K | $83.0K | $84.0K | $76.0K | $74.0K | $74.0K | $72.0K | $71.0K | $73.0K | $71.0K | $70.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $919.0K | $4M | $2M | $1M | $863.0K | $2M | |
| Other Non-cash | · | $-4M | · | · | · | $-909.0K | · | · | · | $-2M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-19M | $-22M | $-2M | $-15M | $-16M | $-17M | $-14M | $-14M | $-10M | $-13M | $-11M | $-10M | $-10M | $-14M | $-9M | $-20M | |
| CapEx | $254.0K | $184.0K | $33.0K | $310.0K | $34.0K | $112.0K | $106.0K | $68.0K | $107.0K | $8.0K | $-3.0K | $19.0K | $27.0K | $35.0K | $54.0K | $224.0K | |
| Investing Cash Flow | $-23M | $10M | $-18M | $-39M | $16M | $13M | $-4M | $557.0K | $10M | $6M | $33M | $13M | $8M | $-44M | $-63M | $-224.0K | |
| Financing Cash Flow | $35M | $6M | $13M | $76M | $-428.0K | $-296.0K | $14M | $15M | $171.0K | $18.0K | $-11M | $4.0K | $86.0K | $57M | $-5M | $-2M | |
| Net Change in Cash | $-8M | $-6M | $-7M | $23M | $401.0K | $-4M | $-3M | $2M | $389.0K | $-7M | $11M | $3M | $-2M | $-1M | $-77M | $88M | |
| Free Cash Flow | · | $-22M | · | · | · | $-17M | · | · | · | $-13M | · | · | · | $-14M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25404.5% | -20069.1% | · | -2359.2% | -2311.8% | -2179.8% | · | -1655.7% | -2167.0% | -2326.3% | · | -3466.3% | -1416.0% | -991.8% | · | · | |
| Net Margin | -26994.3% | -18810.0% | · | -2419.1% | -2316.2% | -2160.7% | · | -1562.9% | -2054.0% | -2171.5% | · | -3178.0% | -1316.5% | -939.9% | · | · | |
| EBITDA Margin | -25404.5% | -19987.3% | · | -2359.2% | -2311.8% | -2170.3% | · | -1655.7% | -2167.0% | -2314.3% | · | -3466.3% | -1416.0% | -985.7% | · | · | |
| ROA | -30.0% | -25.9% | · | -23.1% | -33.6% | -26.5% | · | -16.1% | -16.1% | -12.3% | · | -14.4% | -8.4% | -7.3% | · | -0.59% | |
| ROE | -242.2% | -71.3% | · | -46.3% | -87.2% | -50.7% | · | -24.5% | -23.9% | -17.2% | · | -36.2% | -28.6% | -22.9% | · | 13.8% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 7.0 | · | 4.7 | 2.1 | 3.4 | · | 4.2 | 4.6 | 7.3 | · | 5.1 | 10.1 | 10.8 | · | 0.6 | |
| Quick Ratio | 8.2 | 6.9 | · | 4.6 | 2.0 | 3.2 | · | 4.1 | 4.5 | 7.2 | · | 5.1 | 9.9 | 10.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -32.9 | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.1 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.2 | · | 0.6 | 0.6 | 0.4 | · | · | |
| Receivables Turnover | 1.3 | 1.3 | · | 10.3 | 10.3 | 11.1 | · | 9.8 | 6.2 | 8.7 | · | 9.7 | 10.7 | 30.6 | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.32 | $0.70 | · | $0.77 | $0.01 | $0.44 | · | $1.22 | $1.23 | $1.60 | · | $2.23 | $2.50 | $3.14 | · | $-1.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.02 | $0.02 | $0.02 | · | $0.03 | $0.02 | $0.02 | · | $0.01 | $0.03 | $0.04 | · | · | |
| Cash Flow / Share | · | $-0.35 | · | · | · | $-0.43 | · | · | · | $-0.37 | · | · | · | $-0.52 | · | · | |
| Cash / Share | $0.34 | $0.48 | · | $0.74 | $0.49 | $0.48 | · | $0.67 | $0.66 | $0.65 | · | $0.53 | $0.46 | $0.59 | · | $0.17 | |
| EPS (TTM) | $-0.83 | $-0.95 | · | $-1.81 | $-1.82 | $-1.77 | · | $-1.59 | $-1.56 | $-1.46 | · | $-1.47 | $-1.60 | $-2.02 | · | $-1.91 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $32M | $33M | · | $3M | $3M | $3M | · | $3M | $2M | $2M | · | $4M | $4M | $4M | · | · | |
| Net Income TTM | $-59M | $-55M | · | $-75M | $-70M | $-66M | · | $-58M | $-56M | $-52M | · | $-46M | $-43M | $-39M | · | $-24M | |
| Market Cap | $259M | $249M | · | $140M | $104M | $164M | · | $195M | $292M | $189M | · | $312M | $250M | $621M | · | $44M | |
| P/E | -5.2 | -4.5 | · | -1.4 | -1.5 | -2.4 | · | -3.2 | -5.2 | -3.6 | · | -5.9 | -4.4 | -9.7 | · | -5.2 | |
| P/S | 8.1 | 7.6 | · | 49.7 | 35.2 | 56.8 | · | 73.7 | 140.4 | 85.1 | · | 86.6 | 57.6 | 162.1 | · | · | |
| P/B | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | -7.3 | |
| P / Tangible Book | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | · | |
| P / Cash Flow | · | -11.2 | · | · | · | -9.9 | · | · | · | -14.4 | · | · | · | -43.2 | · | · | |
| Earnings Yield | -19.2% | -22.4% | · | -73.0% | -67.9% | -41.4% | · | -30.9% | -19.1% | -27.7% | · | -16.9% | -22.9% | -10.3% | · | -19.3% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $33M | $3M | $3M | $4M | · |
| 营业利润率 % | -154.7% | -2437.5% | -1866.2% | · | · |
| 净收入 | $-53M | $-61M | $-49M | $-34M | $-378.8K |
| 稀释后每股收益 (EPS) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 6.4 | 4.3 | 8.0 | 0.2 | 10.9 |
| 速动比率 | 6.4 | 4.1 | 7.8 | 0.1 | 10.6 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-49M | $-51M | $-46M | · | · |
机构持有人 (13F) 86 家申报者 · $124.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
86
持有价值
$124.3M
新仓位
27
已退出持仓
13
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 27 (+8 与上一季度对比) | 13 (0 与上一季度对比) | 22 (-2 与上一季度对比) | 15 (+1 与上一季度对比) | +4.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $41234412 | 9556063 | 33.19% | 股份 |
| PERCEPTIVE ADVISORS LLC | $21738564 | 5037906 | 17.50% | 股份 |
| BlackRock, Inc. | $10832320 | 2510387 | 8.72% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8728883 | 2022916 | 7.03% | 股份 |
| VANGUARD GROUP INC | $6658907 | 1604556 | 5.36% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $4350317 | 1007908 | 3.50% | 股份 |
| Alyeska Investment Group, L.P. | $4315000 | 1000000 | 3.47% | 股份 |
| Propel Bio Management, LLC | $3869265 | 896701 | 3.11% | 股份 |
| STATE STREET CORP | $2226756 | 516050 | 1.79% | 股份 |
| RICE HALL JAMES & ASSOCIATES, LLC | $1829560 | 424000 | 1.47% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1508282 | 349544 | 1.21% | 股份 |
| NORTHERN TRUST CORP | $1482807 | 343640 | 1.19% | 股份 |
| UBS Group AG | $1405711 | 325773 | 1.13% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1261072 | 292253 | 1.01% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1186508 | 274973 | 0.95% | 股份 |
| Knott David M Jr | $1094504 | 253651 | 0.88% | 股份 |
| Flat Footed LLC | $1084670 | 251372 | 0.87% | 股份 |
| Simplify Asset Management Inc. | $946655 | 219387 | 0.76% | 股份 |
| GOLDMAN SACHS GROUP INC | $775000 | 179606 | 0.62% | 股份 |
| DAFNA Capital Management LLC | $547319 | 126841 | 0.44% | 股份 |
| AMH Equity Ltd | $411680 | 166000 | 0.33% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $388350 | 90000 | 0.31% | 股份 |
| IFP Advisors, Inc | $386659 | 89608 | 0.31% | 股份 |
| Daytona Street Capital LLC | $379336 | 96398 | 0.31% | 股份 |
| Bank of New York Mellon Corp | $371534 | 86103 | 0.30% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347789 | 80600 | 0.28% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $283944 | 65804 | 0.23% | 股份 |
| CITADEL ADVISORS LLC | $242464 | 56191 | 0.20% | 股份 |
| Nuveen, LLC | $224889 | 52118 | 0.18% | 股份 |
| Holos Integrated Wealth LLC | $204316 | 51595 | 0.16% | 股份 |
| Cubist Systematic Strategies, LLC | $193172 | 77892 | 0.16% | 股份 |
| NewEdge Advisors, LLC | $190218 | 44083 | 0.15% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $187642 | 43486 | 0.15% | 股份 |
| DEUTSCHE BANK AG\ | $171383 | 39672 | 0.14% | 股份 |
| XTX Topco Ltd | $167482 | 38814 | 0.13% | 股份 |
| WELLS FARGO & COMPANY/MN | $156876 | 36356 | 0.13% | 股份 |
| HighTower Advisors, LLC | $152643 | 35375 | 0.12% | 股份 |
| LASRY MARC | $150955 | 60869 | 0.12% | 股份 |
| Affinity Asset Advisors, LLC | $144121 | 33400 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $137813 | 31940 | 0.11% | 股份 |
| MORGAN STANLEY | $125826 | 29160 | 0.10% | 股份 |
| ALGERT GLOBAL LLC | $122917 | 28486 | 0.10% | 股份 |
| Meramec Financial Planners, LLC | $114600 | 30000 | 0.09% | 股份 |
| TWO SIGMA ADVISERS, LP | $112465 | 27100 | 0.09% | 股份 |
| AXQ CAPITAL, LP | $109808 | 25448 | 0.09% | 股份 |
| Invesco Ltd. | $106533 | 24689 | 0.09% | 股份 |
| MetLife Investment Management, LLC | $103534 | 23994 | 0.08% | 股份 |
| BANK OF AMERICA CORP /DE/ | $102792 | 23822 | 0.08% | 股份 |
| JPMORGAN CHASE & CO | $99181 | 20880 | 0.08% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $97359 | 22563 | 0.08% | 股份 |
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RTW Investments, LP, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., Roderick Wong ×8 申报 | 2026年4月29日 | 19.20% | 修订 | · | SEC |
| HSAC 2 Holdings, LLC ×3 申报 | 2024年8月7日 | · | 初始申报 | · | SEC |
| Geoffrey W. Smith | 2023年2月7日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 21 位内幕人士 · 11 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| David P Hochman | Chief Executive Officer and Chairperson | 2026年9月10日 F | 432916 | 5 | 0 | $149150 |
| Roderick Wong, M.D. | Chief Executive Officer | 2023年1月24日 P | 2808512 | 0 | 0 | $0 |
| Andrew Lawrence Taylor | Chief Financial Officer | 2026年8月26日 F | 589989 | 0 | 0 | $0 |
| Michael Kaswan | Chief Financial Officer | 2023年1月26日 A | 162574 | 0 | 0 | $0 |
| Darren Sherman | President and Chief Operating Officer | 2026年10月1日 S | 1119402 | 1 | 5 | $-342290 |
| Joshua Aiello | Principal Accounting Officer | 2026年8月26日 F | 18441 | 0 | 0 | $0 |
| William Reed Little | Executive Vice President, Corporate Development & Strategy | 2024年5月30日 P | 307859 | 0 | 0 | $0 |
| George Papandreou | General Manager and Senior Vice President, Focal Therapies | 2024年5月8日 A | 42000 | 0 | 0 | $0 |
| Yuval Mika | General Manager and Chief Technology Officer, Bioelectronic Therapies | 2024年5月8日 A | 158905 | 0 | 0 | $0 |
| Stephanie A Sirota | VP of Corp Stratege and Comm | 2020年8月4日 P | 20000 | 0 | 0 | $0 |
| Alice Lee | VP Operations, Sec & Treasurer | 2020年8月4日 P | 10000 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | 董事 | 2026年6月23日 A | 66038 | 0 | 0 | $0 |
| Jason Aryeh | 董事 | 2026年6月23日 A | 118118 | 2 | 0 | $37481 |
| Eric A Rose MD | 董事 | 2024年6月20日 A | 7544 | 0 | 0 | $0 |
| Geoffrey Wade Smith | 董事 | 2023年7月20日 A | 20913 | 0 | 0 | $0 |
| HSAC 2 Holdings, LLC | 10% 所有者 | 2024年8月5日 J | 1705705 | 0 | 0 | $0 |
| Medtronic plc | 10% 所有者 | 2023年1月30日 P | 4999423 | 0 | 0 | $0 |
| Chris Cleary | · | 2026年8月12日 F | 29153 | 0 | 0 | $0 |
| John Prosper Mack | · | 2026年8月12日 F | 66544 | 0 | 0 | $0 |
| David Pacitti | · | 2026年8月12日 F | 54750 | 0 | 0 | $0 |
| Eric S Fain | · | 2026年8月12日 F | 99630 | 1 | 0 | $82600 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 10 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.05% | 135778 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.03% | 4255 SH | 2026年10月2日 | 每日 |
| IWO · iShares Trust | 0.02% | 374286 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 228058 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 42916 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 815602 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.01% | 19057 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 498632 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1470063 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3999 SH | 2026年8月19日 | 每日 |
OBIO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$11.00
+84.9%
3 23.1%
强烈买入
8 61.5%
买入
2 15.4%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-10-03平均目标 $12.43 +108.9%
← 低于所有目标
当前价格 $5.95
最低$9.00
平均值$12.43
最高$20.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| MOBI | · | · | · | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报